カテゴリー： LP Information, 世界, 医療/バイオ

世界のエイズ迅速検査市場予測 2023年-2029年

◆英語タイトル：Global Rapid AIDS Test Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU7850）◆商品コード：LP23JU7850
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：108
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のエイズ迅速検査市場」は、過去の販売実績から2022年の世界のエイズ迅速検査の総販売量を検討し、2023年から2029年の予測されるエイズ迅速検査の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のエイズ迅速検査の市場規模を掲載し、XXX百万米ドル規模の世界のエイズ迅速検査市場の詳細な分析を提供します。本インサイトレポートは、世界のエイズ迅速検査業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のエイズ迅速検査市場における各社の独自のポジションをより深く理解するために、エイズ迅速検査製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のエイズ迅速検査市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。エイズ迅速検査の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。エイズ迅速検査の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。エイズ迅速検査のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

エイズ迅速検査の世界主要メーカーとしては、Maccura Biotechnology、 Alere、 Hologic、 Diagnosis、 Chembio Diagnostic Systems、 NanoEntek、 Orasure Technologies、 MedMira、 Turklab、 Atomo Diagnostics、 LifeSignなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のエイズ迅速検査市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではエイズ迅速検査市場をセグメンテーションし、種類別 (血液検査紙、唾液検査紙、その他)、用途別 (家庭、病院、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：血液検査紙、唾液検査紙、その他

・用途別区分：家庭、病院、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のエイズ迅速検査市場の10年間の市場状況・展望は？
・世界および地域別に見たエイズ迅速検査市場成長の要因は何か？
・エイズ迅速検査の市場機会はエンドマーケットの規模によってどのように変化するのか？
・エイズ迅速検査のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：エイズ迅速検査の年間販売量2018-2029、地域別現状・将来分析
・エイズ迅速検査の種類別セグメント：血液検査紙、唾液検査紙、その他
・エイズ迅速検査の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・エイズ迅速検査の用途別セグメント：家庭、病院、その他
・エイズ迅速検査の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のエイズ迅速検査市場
・企業別のグローバルエイズ迅速検査市場データ：2018-2023年の年間販売量、市場シェア
・企業別のエイズ迅速検査の年間売上：2018-2023年の売上、市場シェア
・企業別のエイズ迅速検査販売価格
・主要企業のエイズ迅速検査生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

エイズ迅速検査の地域別レビュー
・地域別のエイズ迅速検査市場規模2018-2023：年間販売量、売上
・主要国別のエイズ迅速検査市場規模2018-2023：年間販売量、売上
・南北アメリカのエイズ迅速検査販売の成長
・アジア太平洋のエイズ迅速検査販売の成長
・ヨーロッパのエイズ迅速検査販売の成長
・中東・アフリカのエイズ迅速検査販売の成長

南北アメリカ市場
・南北アメリカの国別のエイズ迅速検査販売量、売上（2018-2023）
・南北アメリカのエイズ迅速検査の種類別販売量
・南北アメリカのエイズ迅速検査の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のエイズ迅速検査販売量、売上（2018-2023）
・アジア太平洋のエイズ迅速検査の種類別販売量
・アジア太平洋のエイズ迅速検査の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のエイズ迅速検査販売量、売上（2018-2023）
・ヨーロッパのエイズ迅速検査の種類別販売量
・ヨーロッパのエイズ迅速検査の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のエイズ迅速検査販売量、売上（2018-2023）
・中東・アフリカのエイズ迅速検査の種類別販売量
・中東・アフリカのエイズ迅速検査の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・エイズ迅速検査の製造コスト構造分析
・エイズ迅速検査の製造プロセス分析
・エイズ迅速検査の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・エイズ迅速検査の主要なグローバル販売業者
・エイズ迅速検査の主要なグローバル顧客

地域別のエイズ迅速検査市場予測レビュー
・地域別のエイズ迅速検査市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・エイズ迅速検査の種類別市場規模予測
・エイズ迅速検査の用途別市場規模予測

主要企業分析
Maccura Biotechnology、 Alere、 Hologic、 Diagnosis、 Chembio Diagnostic Systems、 NanoEntek、 Orasure Technologies、 MedMira、 Turklab、 Atomo Diagnostics、 LifeSign
・企業情報
・エイズ迅速検査製品
・エイズ迅速検査販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

AIDS test strips are a new generation of test reagents developed using colloidal gold immunochromatography technology, which can detect HIV-1/2 specific antibodies in serum or plasma samples.
LPI (LP Information)’ newest research report, the “Rapid AIDS Test Industry Forecast” looks at past sales and reviews total world Rapid AIDS Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid AIDS Test sales for 2023 through 2029. With Rapid AIDS Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid AIDS Test industry.
This Insight Report provides a comprehensive analysis of the global Rapid AIDS Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid AIDS Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid AIDS Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid AIDS Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid AIDS Test.
The global Rapid AIDS Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rapid AIDS Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rapid AIDS Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rapid AIDS Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rapid AIDS Test players cover Maccura Biotechnology, Alere, Hologic, Diagnosis, Chembio Diagnostic Systems, NanoEntek, Orasure Technologies, MedMira and Turklab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid AIDS Test market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Test Paper
Saliva Test Paper
Other
Segmentation by application
Home
Hospital
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Maccura Biotechnology
Alere
Hologic
Diagnosis
Chembio Diagnostic Systems
NanoEntek
Orasure Technologies
MedMira
Turklab
Atomo Diagnostics
LifeSign
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid AIDS Test market?
What factors are driving Rapid AIDS Test market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid AIDS Test market opportunities vary by end market size?
How does Rapid AIDS Test break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid AIDS Test Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rapid AIDS Test by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rapid AIDS Test by Country/Region, 2018, 2022 & 2029
2.2 Rapid AIDS Test Segment by Type
2.2.1 Blood Test Paper
2.2.2 Saliva Test Paper
2.2.3 Other
2.3 Rapid AIDS Test Sales by Type
2.3.1 Global Rapid AIDS Test Sales Market Share by Type (2018-2023)
2.3.2 Global Rapid AIDS Test Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rapid AIDS Test Sale Price by Type (2018-2023)
2.4 Rapid AIDS Test Segment by Application
2.4.1 Home
2.4.2 Hospital
2.4.3 Other
2.5 Rapid AIDS Test Sales by Application
2.5.1 Global Rapid AIDS Test Sale Market Share by Application (2018-2023)
2.5.2 Global Rapid AIDS Test Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rapid AIDS Test Sale Price by Application (2018-2023)
3 Global Rapid AIDS Test by Company
3.1 Global Rapid AIDS Test Breakdown Data by Company
3.1.1 Global Rapid AIDS Test Annual Sales by Company (2018-2023)
3.1.2 Global Rapid AIDS Test Sales Market Share by Company (2018-2023)
3.2 Global Rapid AIDS Test Annual Revenue by Company (2018-2023)
3.2.1 Global Rapid AIDS Test Revenue by Company (2018-2023)
3.2.2 Global Rapid AIDS Test Revenue Market Share by Company (2018-2023)
3.3 Global Rapid AIDS Test Sale Price by Company
3.4 Key Manufacturers Rapid AIDS Test Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rapid AIDS Test Product Location Distribution
3.4.2 Players Rapid AIDS Test Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rapid AIDS Test by Geographic Region
4.1 World Historic Rapid AIDS Test Market Size by Geographic Region (2018-2023)
4.1.1 Global Rapid AIDS Test Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rapid AIDS Test Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rapid AIDS Test Market Size by Country/Region (2018-2023)
4.2.1 Global Rapid AIDS Test Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rapid AIDS Test Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rapid AIDS Test Sales Growth
4.4 APAC Rapid AIDS Test Sales Growth
4.5 Europe Rapid AIDS Test Sales Growth
4.6 Middle East & Africa Rapid AIDS Test Sales Growth
5 Americas
5.1 Americas Rapid AIDS Test Sales by Country
5.1.1 Americas Rapid AIDS Test Sales by Country (2018-2023)
5.1.2 Americas Rapid AIDS Test Revenue by Country (2018-2023)
5.2 Americas Rapid AIDS Test Sales by Type
5.3 Americas Rapid AIDS Test Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid AIDS Test Sales by Region
6.1.1 APAC Rapid AIDS Test Sales by Region (2018-2023)
6.1.2 APAC Rapid AIDS Test Revenue by Region (2018-2023)
6.2 APAC Rapid AIDS Test Sales by Type
6.3 APAC Rapid AIDS Test Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rapid AIDS Test by Country
7.1.1 Europe Rapid AIDS Test Sales by Country (2018-2023)
7.1.2 Europe Rapid AIDS Test Revenue by Country (2018-2023)
7.2 Europe Rapid AIDS Test Sales by Type
7.3 Europe Rapid AIDS Test Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid AIDS Test by Country
8.1.1 Middle East & Africa Rapid AIDS Test Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rapid AIDS Test Revenue by Country (2018-2023)
8.2 Middle East & Africa Rapid AIDS Test Sales by Type
8.3 Middle East & Africa Rapid AIDS Test Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rapid AIDS Test
10.3 Manufacturing Process Analysis of Rapid AIDS Test
10.4 Industry Chain Structure of Rapid AIDS Test
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rapid AIDS Test Distributors
11.3 Rapid AIDS Test Customer
12 World Forecast Review for Rapid AIDS Test by Geographic Region
12.1 Global Rapid AIDS Test Market Size Forecast by Region
12.1.1 Global Rapid AIDS Test Forecast by Region (2024-2029)
12.1.2 Global Rapid AIDS Test Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rapid AIDS Test Forecast by Type
12.7 Global Rapid AIDS Test Forecast by Application
13 Key Players Analysis
13.1 Maccura Biotechnology
13.1.1 Maccura Biotechnology Company Information
13.1.2 Maccura Biotechnology Rapid AIDS Test Product Portfolios and Specifications
13.1.3 Maccura Biotechnology Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Maccura Biotechnology Main Business Overview
13.1.5 Maccura Biotechnology Latest Developments
13.2 Alere
13.2.1 Alere Company Information
13.2.2 Alere Rapid AIDS Test Product Portfolios and Specifications
13.2.3 Alere Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alere Main Business Overview
13.2.5 Alere Latest Developments
13.3 Hologic
13.3.1 Hologic Company Information
13.3.2 Hologic Rapid AIDS Test Product Portfolios and Specifications
13.3.3 Hologic Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hologic Main Business Overview
13.3.5 Hologic Latest Developments
13.4 Diagnosis
13.4.1 Diagnosis Company Information
13.4.2 Diagnosis Rapid AIDS Test Product Portfolios and Specifications
13.4.3 Diagnosis Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Diagnosis Main Business Overview
13.4.5 Diagnosis Latest Developments
13.5 Chembio Diagnostic Systems
13.5.1 Chembio Diagnostic Systems Company Information
13.5.2 Chembio Diagnostic Systems Rapid AIDS Test Product Portfolios and Specifications
13.5.3 Chembio Diagnostic Systems Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chembio Diagnostic Systems Main Business Overview
13.5.5 Chembio Diagnostic Systems Latest Developments
13.6 NanoEntek
13.6.1 NanoEntek Company Information
13.6.2 NanoEntek Rapid AIDS Test Product Portfolios and Specifications
13.6.3 NanoEntek Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 NanoEntek Main Business Overview
13.6.5 NanoEntek Latest Developments
13.7 Orasure Technologies
13.7.1 Orasure Technologies Company Information
13.7.2 Orasure Technologies Rapid AIDS Test Product Portfolios and Specifications
13.7.3 Orasure Technologies Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Orasure Technologies Main Business Overview
13.7.5 Orasure Technologies Latest Developments
13.8 MedMira
13.8.1 MedMira Company Information
13.8.2 MedMira Rapid AIDS Test Product Portfolios and Specifications
13.8.3 MedMira Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MedMira Main Business Overview
13.8.5 MedMira Latest Developments
13.9 Turklab
13.9.1 Turklab Company Information
13.9.2 Turklab Rapid AIDS Test Product Portfolios and Specifications
13.9.3 Turklab Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Turklab Main Business Overview
13.9.5 Turklab Latest Developments
13.10 Atomo Diagnostics
13.10.1 Atomo Diagnostics Company Information
13.10.2 Atomo Diagnostics Rapid AIDS Test Product Portfolios and Specifications
13.10.3 Atomo Diagnostics Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Atomo Diagnostics Main Business Overview
13.10.5 Atomo Diagnostics Latest Developments
13.11 LifeSign
13.11.1 LifeSign Company Information
13.11.2 LifeSign Rapid AIDS Test Product Portfolios and Specifications
13.11.3 LifeSign Rapid AIDS Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 LifeSign Main Business Overview
13.11.5 LifeSign Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rapid AIDS Test Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rapid AIDS Test Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Blood Test Paper
Table 4. Major Players of Saliva Test Paper
Table 5. Major Players of Other
Table 6. Global Rapid AIDS Test Sales by Type (2018-2023) & (K Units)
Table 7. Global Rapid AIDS Test Sales Market Share by Type (2018-2023)
Table 8. Global Rapid AIDS Test Revenue by Type (2018-2023) & ($ million)
Table 9. Global Rapid AIDS Test Revenue Market Share by Type (2018-2023)
Table 10. Global Rapid AIDS Test Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Rapid AIDS Test Sales by Application (2018-2023) & (K Units)
Table 12. Global Rapid AIDS Test Sales Market Share by Application (2018-2023)
Table 13. Global Rapid AIDS Test Revenue by Application (2018-2023)
Table 14. Global Rapid AIDS Test Revenue Market Share by Application (2018-2023)
Table 15. Global Rapid AIDS Test Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Rapid AIDS Test Sales by Company (2018-2023) & (K Units)
Table 17. Global Rapid AIDS Test Sales Market Share by Company (2018-2023)
Table 18. Global Rapid AIDS Test Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Rapid AIDS Test Revenue Market Share by Company (2018-2023)
Table 20. Global Rapid AIDS Test Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Rapid AIDS Test Producing Area Distribution and Sales Area
Table 22. Players Rapid AIDS Test Products Offered
Table 23. Rapid AIDS Test Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Rapid AIDS Test Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Rapid AIDS Test Sales Market Share Geographic Region (2018-2023)
Table 28. Global Rapid AIDS Test Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Rapid AIDS Test Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Rapid AIDS Test Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Rapid AIDS Test Sales Market Share by Country/Region (2018-2023)
Table 32. Global Rapid AIDS Test Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Rapid AIDS Test Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Rapid AIDS Test Sales by Country (2018-2023) & (K Units)
Table 35. Americas Rapid AIDS Test Sales Market Share by Country (2018-2023)
Table 36. Americas Rapid AIDS Test Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Rapid AIDS Test Revenue Market Share by Country (2018-2023)
Table 38. Americas Rapid AIDS Test Sales by Type (2018-2023) & (K Units)
Table 39. Americas Rapid AIDS Test Sales by Application (2018-2023) & (K Units)
Table 40. APAC Rapid AIDS Test Sales by Region (2018-2023) & (K Units)
Table 41. APAC Rapid AIDS Test Sales Market Share by Region (2018-2023)
Table 42. APAC Rapid AIDS Test Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Rapid AIDS Test Revenue Market Share by Region (2018-2023)
Table 44. APAC Rapid AIDS Test Sales by Type (2018-2023) & (K Units)
Table 45. APAC Rapid AIDS Test Sales by Application (2018-2023) & (K Units)
Table 46. Europe Rapid AIDS Test Sales by Country (2018-2023) & (K Units)
Table 47. Europe Rapid AIDS Test Sales Market Share by Country (2018-2023)
Table 48. Europe Rapid AIDS Test Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Rapid AIDS Test Revenue Market Share by Country (2018-2023)
Table 50. Europe Rapid AIDS Test Sales by Type (2018-2023) & (K Units)
Table 51. Europe Rapid AIDS Test Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Rapid AIDS Test Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Rapid AIDS Test Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Rapid AIDS Test Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Rapid AIDS Test Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Rapid AIDS Test Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Rapid AIDS Test Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Rapid AIDS Test
Table 59. Key Market Challenges & Risks of Rapid AIDS Test
Table 60. Key Industry Trends of Rapid AIDS Test
Table 61. Rapid AIDS Test Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Rapid AIDS Test Distributors List
Table 64. Rapid AIDS Test Customer List
Table 65. Global Rapid AIDS Test Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Rapid AIDS Test Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Rapid AIDS Test Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Rapid AIDS Test Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Rapid AIDS Test Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Rapid AIDS Test Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Rapid AIDS Test Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Rapid AIDS Test Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Rapid AIDS Test Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Rapid AIDS Test Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Rapid AIDS Test Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Rapid AIDS Test Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Rapid AIDS Test Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Rapid AIDS Test Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Maccura Biotechnology Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 80. Maccura Biotechnology Rapid AIDS Test Product Portfolios and Specifications
Table 81. Maccura Biotechnology Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Maccura Biotechnology Main Business
Table 83. Maccura Biotechnology Latest Developments
Table 84. Alere Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 85. Alere Rapid AIDS Test Product Portfolios and Specifications
Table 86. Alere Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Alere Main Business
Table 88. Alere Latest Developments
Table 89. Hologic Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 90. Hologic Rapid AIDS Test Product Portfolios and Specifications
Table 91. Hologic Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Hologic Main Business
Table 93. Hologic Latest Developments
Table 94. Diagnosis Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 95. Diagnosis Rapid AIDS Test Product Portfolios and Specifications
Table 96. Diagnosis Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Diagnosis Main Business
Table 98. Diagnosis Latest Developments
Table 99. Chembio Diagnostic Systems Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 100. Chembio Diagnostic Systems Rapid AIDS Test Product Portfolios and Specifications
Table 101. Chembio Diagnostic Systems Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Chembio Diagnostic Systems Main Business
Table 103. Chembio Diagnostic Systems Latest Developments
Table 104. NanoEntek Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 105. NanoEntek Rapid AIDS Test Product Portfolios and Specifications
Table 106. NanoEntek Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. NanoEntek Main Business
Table 108. NanoEntek Latest Developments
Table 109. Orasure Technologies Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 110. Orasure Technologies Rapid AIDS Test Product Portfolios and Specifications
Table 111. Orasure Technologies Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Orasure Technologies Main Business
Table 113. Orasure Technologies Latest Developments
Table 114. MedMira Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 115. MedMira Rapid AIDS Test Product Portfolios and Specifications
Table 116. MedMira Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. MedMira Main Business
Table 118. MedMira Latest Developments
Table 119. Turklab Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 120. Turklab Rapid AIDS Test Product Portfolios and Specifications
Table 121. Turklab Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Turklab Main Business
Table 123. Turklab Latest Developments
Table 124. Atomo Diagnostics Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 125. Atomo Diagnostics Rapid AIDS Test Product Portfolios and Specifications
Table 126. Atomo Diagnostics Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Atomo Diagnostics Main Business
Table 128. Atomo Diagnostics Latest Developments
Table 129. LifeSign Basic Information, Rapid AIDS Test Manufacturing Base, Sales Area and Its Competitors
Table 130. LifeSign Rapid AIDS Test Product Portfolios and Specifications
Table 131. LifeSign Rapid AIDS Test Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. LifeSign Main Business
Table 133. LifeSign Latest Developments
List of Figures
Figure 1. Picture of Rapid AIDS Test
Figure 2. Rapid AIDS Test Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rapid AIDS Test Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rapid AIDS Test Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rapid AIDS Test Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Blood Test Paper
Figure 10. Product Picture of Saliva Test Paper
Figure 11. Product Picture of Other
Figure 12. Global Rapid AIDS Test Sales Market Share by Type in 2022
Figure 13. Global Rapid AIDS Test Revenue Market Share by Type (2018-2023)
Figure 14. Rapid AIDS Test Consumed in Home
Figure 15. Global Rapid AIDS Test Market: Home (2018-2023) & (K Units)
Figure 16. Rapid AIDS Test Consumed in Hospital
Figure 17. Global Rapid AIDS Test Market: Hospital (2018-2023) & (K Units)
Figure 18. Rapid AIDS Test Consumed in Other
Figure 19. Global Rapid AIDS Test Market: Other (2018-2023) & (K Units)
Figure 20. Global Rapid AIDS Test Sales Market Share by Application (2022)
Figure 21. Global Rapid AIDS Test Revenue Market Share by Application in 2022
Figure 22. Rapid AIDS Test Sales Market by Company in 2022 (K Units)
Figure 23. Global Rapid AIDS Test Sales Market Share by Company in 2022
Figure 24. Rapid AIDS Test Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Rapid AIDS Test Revenue Market Share by Company in 2022
Figure 26. Global Rapid AIDS Test Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Rapid AIDS Test Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Rapid AIDS Test Sales 2018-2023 (K Units)
Figure 29. Americas Rapid AIDS Test Revenue 2018-2023 ($ Millions)
Figure 30. APAC Rapid AIDS Test Sales 2018-2023 (K Units)
Figure 31. APAC Rapid AIDS Test Revenue 2018-2023 ($ Millions)
Figure 32. Europe Rapid AIDS Test Sales 2018-2023 (K Units)
Figure 33. Europe Rapid AIDS Test Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Rapid AIDS Test Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Rapid AIDS Test Revenue 2018-2023 ($ Millions)
Figure 36. Americas Rapid AIDS Test Sales Market Share by Country in 2022
Figure 37. Americas Rapid AIDS Test Revenue Market Share by Country in 2022
Figure 38. Americas Rapid AIDS Test Sales Market Share by Type (2018-2023)
Figure 39. Americas Rapid AIDS Test Sales Market Share by Application (2018-2023)
Figure 40. United States Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Rapid AIDS Test Sales Market Share by Region in 2022
Figure 45. APAC Rapid AIDS Test Revenue Market Share by Regions in 2022
Figure 46. APAC Rapid AIDS Test Sales Market Share by Type (2018-2023)
Figure 47. APAC Rapid AIDS Test Sales Market Share by Application (2018-2023)
Figure 48. China Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Rapid AIDS Test Sales Market Share by Country in 2022
Figure 56. Europe Rapid AIDS Test Revenue Market Share by Country in 2022
Figure 57. Europe Rapid AIDS Test Sales Market Share by Type (2018-2023)
Figure 58. Europe Rapid AIDS Test Sales Market Share by Application (2018-2023)
Figure 59. Germany Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Rapid AIDS Test Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Rapid AIDS Test Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Rapid AIDS Test Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Rapid AIDS Test Sales Market Share by Application (2018-2023)
Figure 68. Egypt Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Rapid AIDS Test Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Rapid AIDS Test in 2022
Figure 74. Manufacturing Process Analysis of Rapid AIDS Test
Figure 75. Industry Chain Structure of Rapid AIDS Test
Figure 76. Channels of Distribution
Figure 77. Global Rapid AIDS Test Sales Market Forecast by Region (2024-2029)
Figure 78. Global Rapid AIDS Test Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Rapid AIDS Test Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Rapid AIDS Test Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Rapid AIDS Test Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Rapid AIDS Test Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のエイズ迅速検査市場予測 2023年-2029年(Global Rapid AIDS Test Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のがん迅速検査キット市場予測 2023年-2029年
  • 世界の迅速診断検査キット市場予測 2023年-2029年
  • 世界の移動式補助器具市場予測 2023年-2029年
  • エイズ検査キットのグローバル市場予測2023-2029
  • 世界の肥料用造粒助剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆